South Korean AI-based pharma firm Oncocross secures $14m Series B

South Korean AI-based pharma firm Oncocross secures $14m Series B

Source: Laurynas Mereckas/Unsplash

Quynh Nguyen

11 September, 2020

GNTech Venture CapitalOncocrossSmilegate Investment

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Rest of Asia

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.